NYSE
ARMK
Last Price
US $58.00
KEY FIGURES
MKT CAP
$15.3B
EPS
TTM
$1.36
PEG
TTM
0.13x
P/E
TTM
42.75x
P/S
TTM
0.79x
YIELD
0.80%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
11.23%
Return on equity
ROIC: 5.78%
Valuation History
42.6X
Price to Earnings
EV/EBITDA: 15.9X
Cash flow
Profit margin
7.60%
(FY vs FY)
EBITDA Y/Y
29.95%
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $58.00
—
Default assumptions
EBITDA Multiple
Fair Value
Market $58.00
-76.00%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Aramark cash flow to debt ratio of 16.10% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Aramark's free cash flow has increased 51.95% from $299.09M last year to $454.46M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Aramark's debt to equity ratio is 1.96, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Aramark's debt has increased relative to shareholder equity from 1.83 last year to 1.96 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Aramark has a net debt to EBITDA ratio of 4.07x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Aramark's interest coverage ratio of 2.41 indicates that earnings with margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Aramark's profit margin has increased (21.90%) in the last year from 1.51% to 1.84%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Aramark's short-term liabilities of $3.55G exceed its short-term assets of $3.52G, signaling financial risk
Decreasing performance - ROA.
Aramark's return on assets of 2.58% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Aramark's return on equity of 11.23%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Aramark's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Aramark had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Aramark has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Aramark has a free cash flow yield of 2.98%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Aramark's yearly earnings has increased 24.33% since last year from $262.52M to $326.39M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Aramark's yearly revenue has increased 6.35% since last year from $17.40G to $18.51G, signaling increasing performance
Increasing performance - ROIC.
ROIC 5.78% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Aramark's 3-year revenue CAGR of 10.58% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Aramark had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Aramark had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Aramark has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Aramark has an earnings yield of 2.34%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Aramark is overvalued relative to its fair value price of 13.92 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Aramark has an EV/EBITDA ratio of 16.28x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Aramark has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Aramark has a price-to-book ratio of 4.57x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Aramark has a price-to-sales ratio of 0.79x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue